Extracellular vesicle transfer of lncRNA H19 splice variants to cardiac cells
2024

Healing the heart, one variant at a time

Commentary Evidence: moderate

Author Information

Author(s): Mohsin Sadia, Yang Xiaofeng, Wang Hong, Khan Mohsin

Primary Institution: Lewis Katz School of Medicine, Temple University

Conclusion

The study provides new insights into how lncRNA-H19 splice variants are packaged into extracellular vesicles for targeted delivery to cardiac cells.

Supporting Evidence

  • Extracellular vesicles have low immunogenicity and can deliver diverse signaling molecules.
  • lncRNA-H19 is known to regulate cardiomyocyte numbers and proliferation during cardiac development.
  • The study shows that lncRNA-H19 splice variants are differentially expressed in the heart.

Takeaway

Researchers are exploring how tiny bubbles called extracellular vesicles can help heal the heart by carrying special RNA molecules that can fix heart cells.

Methodology

The study involved engineering Wharton jelly mesenchymal stromal cells with lncRNA-H19 and analyzing the expression of its splice variants in extracellular vesicles.

Limitations

The study does not test the mechanism of lncRNA sorting into extracellular vesicles and highlights potential variability in results between different experimental setups.

Digital Object Identifier (DOI)

10.1016/j.omtn.2024.102407

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication